Conference abstract · 7 Mar 2016
Conference abstract
Pharmaceutical and drug delivery technologies for effecient pain management
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Breakthrough pain in cancer patients is a transitory exacerbation of pain experienced for a short period of time by the patient who has relatively stable and adequately controlled baseline pain. Transmucosal drug delivery through intranasal, sublingual, and buccal mucosa are considered an attractive routes to deliver breakthrough pain management medications. It avoids the hepatic first-pass clearance, which results in enhanced bioavailability and faster onset of drug action. The in-vivo pharmacokinetics of three breakthrough pain drugs has been evaluated in rabbis. Conscious rabbits were used, because anesthesia could impair the nasal mucociliary clearance and thereby allowing the formulations to remain in contact with the nasal mucosa for a longer time than would be normally expected without anesthesia. The same apply for the sublingual delivery to mimic the transient time in clinical use. In two separate experiments, the sublingual administration of Fentanyl and Oxycodone showed promising kinetic profiles, resulting in a rapid absorption with acceptable absolute bioavailability up to 82%. Factors such as formulation viscosity and drug moieties of salt versus free base were also evaluated in light of its effect on absolute bioavailability. Furthermore, Tetrahydrocannabenol (THC) intranasal delivery, also showed acceptable bioavailability comparable to the currently marketed soft gelatin capsules formulations, but irritation to nasal mucous membranes requires further drug formulation efforts to overcome this problem. With the increase demand on enhancing the quality of cancer patientsâ?? life, transmucosal delivery offers compelling opportunities to bring new safe and effective drugs to the market.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 28 Apr 2023
Advances in drug delivery systems: Bridging the gap in pharmaceutical technology.
Perspective · 28 Apr 2023
Nanotechnology applications in drug delivery and revolutionizing pharmaceutical technology.
Commentary · 20 Mar 2023
The Pharmaceutics Science and Technology of Drug Formulation and Delivery
Research article · 4 Apr 2022
Current Approach in Medicinal Chemistry and Pharmaceutical Technology: Strategies for Drug Delivery to the Brain
More from this journal
The newest in Pharmaceutica Analytica Acta.
Article · 16 Sep 2026
The Fc Domains in the Monoclonal Antibody and Fusion Protein Significantly Boost the Biocomposite Suspension's Power to Combat Harmful Microorganisms, Enhance Drug Delivery, and Improve Protein Stability
Article · 26 Jun 2026
Green Pathways in Drug Quality Assessment: The Growing Role of Sustainable Pharmaceutical Analytics
Article · 26 Jun 2026
Advanced Single-Cell Signal Analysis: The Role of Ghost Cytometry in Cell Therapy Characterization
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Abeer Al-Ghananeem”

